UK markets open in 7 hours 9 minutes
  • NIKKEI 225

    -180.63 (-0.65%)

    +471.59 (+2.40%)

    -0.38 (-0.40%)

    -3.80 (-0.21%)
  • DOW

    +27.16 (+0.08%)

    -54.75 (-0.28%)
  • CMC Crypto 200

    -1.61 (-0.28%)
  • ^IXIC

    -74.89 (-0.58%)
  • ^FTAS

    -19.42 (-0.47%)

What is the broker consensus view on Alkem Laboratories?

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

'Buy' and 'sell' recommendations from company analysts often catch the attention of investors - but it's worth remembering that city experts can get things wrong. So rather than relying on just one recommendation, a potentially better way of interpreting broker 'recs' is to take note of the 'consensus' - or average - view of all the analysts covering the stock. That way you get an overall picture of what analysts think.

Take Alkem Laboratories (NSI:ALKEM) as an example. Shares in the company have risen by 1.20% over the past month and they are currently trading at ₹3,173. But what do the analysts that cover the company think?

Based on the broker 'consensus', there could be reasons to believe that the positive recent trend will continue. In terms of trading recommendations, Alkem Laboratories currently has:

  • 11 Buy recommendations

  • 3 Hold recommendations

  • 0 Sell recommendations

This suggests that analysts are generally upbeat about the outlook.

At its current price of ₹3,173, shares in Alkem Laboratories are trading at a discount of -22.0% to its 52 week high price. The 1-year performance of the shares has been -5.31%.

While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of Alkem Laboratories it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Alkem Laboratories that you can find out about here.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting